Hoechst Pakistan Limited (PSX:HPL)

Revance Therapeutics Revenue

Hoechst Pakistan had revenue of 7.57B PKR in the quarter ending March 31, 2025, with 20.46% growth. This brings the company's revenue in the last twelve months to 28.03B, up 22.45% year-over-year. In the year 2024, Hoechst Pakistan had annual revenue of 26.75B with 25.17% growth.

• Revenue (ttm): 28.03B
• Revenue Growth: +22.45%
• P/S Ratio: 1.04
• Revenue / Employee: 33.49M
• Employees: 837
• Market Cap: 29.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	26.75B	5.38B	25.17%
Dec 31, 2023	21.37B	2.81B	15.14%
Dec 31, 2022	18.56B	2.68B	16.87%
Dec 31, 2021	15.88B	1.77B	12.57%
Dec 31, 2020	14.11B	-392.88M	-2.71%